<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药融圈 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-01T11:35:53+08:00</updated>
  <subtitle>药融圈PHARNEX汇聚数万医药大咖，得到数千家医药创业者鼎力支持，开展日常专题讲座。致力于成为“专业、前沿、权威、严谨”的医药行业资讯平台，以及项目、技术、工厂、融资、股权投资等资源整合平台。欢迎您关注药融圈，共同碰撞“药”的火花!</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Belimumab：儿童系统红斑狼疮适应症中国获批；审评报告出炉</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/F1XpAIh39Z6gU9c3gb7oog</id>
    <link href="https://mp.weixin.qq.com/s/F1XpAIh39Z6gU9c3gb7oog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投入超2400万元，苑东生物「硫酸氢氯吡格雷片」获批上市</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/vNToRwBMPUlaoA5vhnxODQ</id>
    <link href="https://mp.weixin.qq.com/s/vNToRwBMPUlaoA5vhnxODQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Myovant和Pfizer达成42亿美元交易，合作开发relugolix及商业化</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/jSD0Kzb4tC65LiNn1hepRQ</id>
    <link href="https://mp.weixin.qq.com/s/jSD0Kzb4tC65LiNn1hepRQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>卫健委：发布「国家短缺药品」清单、「国家临床必需易短缺药品」清单</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/iV-i6_9kjGbMiAtTLjmWYg</id>
    <link href="https://mp.weixin.qq.com/s/iV-i6_9kjGbMiAtTLjmWYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>上海医药：SPH3127获得美国FDA药品II期临床试验资格</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/xhDVrlxEh5RYI0syOfYcaA</id>
    <link href="https://mp.weixin.qq.com/s/xhDVrlxEh5RYI0syOfYcaA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2款印度药获批：太阳药业比卡鲁胺、阿乐滨度泮托拉唑钠肠溶片；37品规药品通过一致性评价；NMPA 12月29日批件信息</title>
    <updated>2020-12-31T17:29:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-31:/s/nNJW1807ef57ZRfcvhT8TA</id>
    <link href="https://mp.weixin.qq.com/s/nNJW1807ef57ZRfcvhT8TA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>SHP2抑制剂全球交易火热；哪些药企在布局？</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/JT5FDICUyvlAbfFlMFrVxQ</id>
    <link href="https://mp.weixin.qq.com/s/JT5FDICUyvlAbfFlMFrVxQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点：2020年全球上市药物汇总</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/r1efxYdDeh-rtwUlNQi4OQ</id>
    <link href="https://mp.weixin.qq.com/s/r1efxYdDeh-rtwUlNQi4OQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>和黄医药开始向美国FDA滚动提交「索凡替尼」新药上市申请</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/upZW6A7rQglv_eAaT5KinQ</id>
    <link href="https://mp.weixin.qq.com/s/upZW6A7rQglv_eAaT5KinQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2知名药企：微芯生物与海正药业达成战略合作</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/H78m5aV7zO16vNnKVsb8wQ</id>
    <link href="https://mp.weixin.qq.com/s/H78m5aV7zO16vNnKVsb8wQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>焕一生物获数千万元天使融资，五源资本助力AI+免疫创新技术发展</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/m0n9X_nlga1EbPXqUmfdyg</id>
    <link href="https://mp.weixin.qq.com/s/m0n9X_nlga1EbPXqUmfdyg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>公告国内ED患者人数约1.4亿人，常山药业被证监局罚</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/DjoTk2BXGmyn__EfVmqc9w</id>
    <link href="https://mp.weixin.qq.com/s/DjoTk2BXGmyn__EfVmqc9w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥赛康药业注射用帕瑞昔布钠通过仿制药一致性评价</title>
    <updated>2020-12-30T22:56:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/JrGzF5mXWYkyt0GbzaUR8w</id>
    <link href="https://mp.weixin.qq.com/s/JrGzF5mXWYkyt0GbzaUR8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【圆满落幕】“中国制药MAH创新大会”暨“MAH制度下的发展与创新”峰会在济南顺利召开！</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/Z9YrXUs5hWdbL9jTTd9iXQ</id>
    <link href="https://mp.weixin.qq.com/s/Z9YrXUs5hWdbL9jTTd9iXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>大战略！绿叶制药与阿斯利康再度携手，积极推进心血管与肿瘤领域深度合作</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/r2IjDBzvFmW0HpYx5z8xfA</id>
    <link href="https://mp.weixin.qq.com/s/r2IjDBzvFmW0HpYx5z8xfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2.31亿美元！再鼎医药引进CLN-081大中华区权益</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/dnvFIitI-VZnHrDRWew7XQ</id>
    <link href="https://mp.weixin.qq.com/s/dnvFIitI-VZnHrDRWew7XQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信立泰8400万元转让两款仿制药，聚焦创新药研发</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/mL0IiGyMc5-Ya0ZwQzNgNA</id>
    <link href="https://mp.weixin.qq.com/s/mL0IiGyMc5-Ya0ZwQzNgNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NMPA发文：药品注册，网上申报，2021年1月1日正式上线</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/lyZvfbIuB0VtgbcbJ3VhjQ</id>
    <link href="https://mp.weixin.qq.com/s/lyZvfbIuB0VtgbcbJ3VhjQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>人福医药(600079.SH)：子公司安立生坦片获得药品注册批件</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/Hf5cd9tw6U-z7Cmou6ztYQ</id>
    <link href="https://mp.weixin.qq.com/s/Hf5cd9tw6U-z7Cmou6ztYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>甘李药业研发CD19/CD22双特异性CAR-T疗法</title>
    <updated>2020-12-30T08:03:57+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-30:/s/1XGzYBQAO9plve_AGMyQvw</id>
    <link href="https://mp.weixin.qq.com/s/1XGzYBQAO9plve_AGMyQvw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>